September 22, 2016/Neurosciences

Cleveland Clinic Telestroke Network at Year 5: Lessons Learned

How to keep remote stroke consult services thriving


By M. Shazam Hussain, MD, and Dana Collins, MBA


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In 2015, stroke neurologists with the Cleveland Clinic Telestroke Network (CCTN) provided remote consultation services to more than 1,000 patients in 15 healthcare facilities in Ohio, Pennsylvania and Florida. We achieved an intravenous tissue plasminogen activator (IV tPA) utilization rate of 16 percent, well above the national average of 3 to 5 percent and nearing the approximately 20 percent achieved by highly specialized centers.

One of the primary reasons for the ongoing success of the CCTN is that it’s a dedicated service line, with stroke neurologists on call 24/7. This level of support for acute stroke patients ensures a rapid response to partner hospitals, which helps improve outcomes. In 2015, the average time from when a CCTN neurologist was paged for a consultation until the physician called back the hospital was one minute.

Nationwide, there are only four neurologists per 100,000 U.S. residents (Neurology. 2013;81:479-486), which makes the need for telestroke services critical. However, implementing and sustaining a telestroke program can be demanding. At Cleveland Clinic, we have tripled our partner hospitals since 2014 and learned some lessons along the way that could benefit other healthcare systems offering telestroke services.


Inception and scope of the CCTN

Launched in 2011, the CCTN is a homegrown program employing a “hub and spoke” model: Our Joint Commission-certified Comprehensive Stroke Center on Cleveland Clinic’s main campus serves as the hub, partnering with “spoke” facilities (within and outside the Cleveland Clinic health system) that lack round-the-clock stroke specialist support. The network is enabled with a mobile, two-way videoconferencing system and a dedicated link between our partner hospitals’ imaging systems and our main campus to facilitate patient assessment and treatment decision support


When patients identified with stroke arrive at the emergency department (ED) of a partner facility, emergency physicians perform a rapid assessment, order a CT scan and then call the CCTN. Within minutes, a CCTN stroke neurologist is working remotely with the ED staff. Together they check vital signs, perform an examination, review results of the CT scan and make treatment decisions.

Since its inception, the CCTN has grown to serve 15 hospitals or freestanding EDs that do not have stroke specialists. This includes eight within the Cleveland Clinic health system as well as seven external facilities — one in Ohio, five in Pennsylvania and one in Florida. The figure below illustrates how two participating hospitals saw their IV tPA delivery rates improve following implementation of telestroke services.

Figure. Delivery rates of IV tPA to patients with acute ischemic stroke at two participating CCTN hospitals during 12-month periods before and after initiation of telestroke services in 2014.

Figure. Delivery rates of IV tPA to patients with acute ischemic stroke at two participating CCTN hospitals during 12-month periods before and after initiation of telestroke services in 2014.

Keeping patients in their communities

Participating in a telestroke program offers several benefits to these 15 facilities, including access to a multidisciplinary team of stroke experts who can help determine the appropriateness of IV tPA administration, intra-arterial thrombolysis, mechanical revascularization and other treatment options.

But the greatest benefit may be that patients often are able to remain in their local hospitals, closer to family and local physicians. We work closely with our partner hospitals, making sure that neurologists and other healthcare staff understand our decision-making and can seamlessly pick up care of the patient the next day and beyond. Only the most severe stroke patients are transferred to Cleveland Clinic’s main campus, which has two neurological ICUs and full neurointerventional and neurosurgical capabilities.


Three prongs of an effective telestroke program

Success of a telestroke program often hinges on three key areas: technology, resources and training. During the five years the CCTN has been in operation, we have gained the following insights in these areas:

  • Technology: A telestroke program requires software, high-quality videoconferencing capabilities, a pan/tilt/zoom camera at partnering facilities, CT image transfer capabilities, and fast, secure transmission systems. We have opted for a high-end system to help safeguard against glitches and downtime. A program’s service line is only as good as its software and real-time transmission capabilities allow.
  • Resources: Telestroke programs run the risk of physician burnout, as they require an immediate response, which can create a higher level of burden on neurologists over time. It’s imperative to have a fairly large pool of stroke experts who rotate shifts. The CCTN comprises 15 stroke neurologists, with one primary telestroke physician and a backup physician on call around the clock.
  • Training: When the CCTN partners with a new participating facility, our program manager facilitates training of the new facility’s entire ED staff to do patient assessments with Cleveland Clinic stroke experts. Topics include components of the NIH Stroke Scale (NIHSS) neurologic exam that require nurse assistance and important reminders related to telemedicine, such as to interact with the physician via the camera. In the past year, the CCTN has begun recommending that two nurses be present in the assessment room at participating facilities — one to interact with the physician, the other to work on the NIHSS exam.

Future of the telestroke network

As a natural extension of the CCTN, Cleveland Clinic launched one of the nation’s first mobile stroke treatment units (MSTUs) in 2014. We also plan to further expand the number of participating CCTN facilities, continually research best-in-class telestroke technology and investigate the use of telemedicine for situations beyond acute stroke, with the ultimate goal of reaching patients faster and improving outcomes.

Dr. Hussain is Head of the Cleveland Clinic Stroke Program and Interim Director of Cleveland Clinic’s Cerebrovascular Center.

Ms. Collins is the Telestroke Program Manager and Department Manager in the Cerebrovascular Center.


Related Articles

pills, syringes and vials on a tabletop
May 15, 2024/Neurosciences/Podcast
Multiple Sclerosis Medications: Making the Most of a Multitude of Options (Podcast)

Insights on the decision process for selecting a treatment approach

neurosurgeon performing minimally invasive spine operation
Top Takeaways From the 2024 AANS Annual Meeting

Scientific program chair reflects on what may resonate longest from this year’s neurosurgery conference

central vein sign on a brain MRI
CAVS-MS Advances Quest to Improve the Diagnosis of Multiple Sclerosis

New reports focus on neuroimaging biomarkers and features of atypical presentations

doctor applying force to patient's forearm to test strength
Offering Rehabilitation Care to Oncology Patients (Podcast)

New oncologic rehab program is tailored to managing the effects of cancer and its treatments

vial of blood labeled "neurofilament light chain"
Could Serum Neurofilament Light Chain Level Help Guide MS Management?

Perhaps, with caveats: sNfL elevation has low sensitivity and lags MRI activity by at least a month

brain puzzle with piece missing and female symbol
Latest WAM Grant Recipients Take on Alzheimer’s Disease in Women Across Multiple Fronts

Awards fund research on oxidative targets, immunometabolism, spatial navigation testing and more

sleepless woman looking at clock
Sleep Apnea and Insomnia Are Highly Prevalent and Linked to Disease Worsening in Neuropsychiatric Disorders

Large cohort study suggests need for routine sleep screening as part of neurological care

neuron affected by neuromyelitis optica
Novel Monoclonal Antibodies for NMOSD Show Strong Efficacy and Safety in Real-World Study

Early experience with the agents confirms findings from clinical trials